Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma.

Adult; Dopamine Agonists/adverse effects/therapeutic use; Ergolines/adverse effects/therapeutic use; Humans; Male; Pituitary Neoplasms/drug therapy; Pneumocephalus/chemically induced; Prolactinoma/drug therapy

Disciplines :

Endocrinology, metabolism & nutrition

Author, co-author :

JOURET, François ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Col, V.

Language :

English

Title :

Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma.

Publication date :

2009

Journal title :

Acta Clinica Belgica

ISSN :

0001-5512

Publisher :

Acta Clinica Belgica, Bruxelles, Belgium

Volume :

Issue :

Pages :

457

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 26 November 2012

Statistics

Number of views

75 (1 by ULiège)

Number of downloads

140 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Molitch ME, Thorner MO, Wilson C. Management of prolactinomas. J Clin Endocrinol Metab 1997; 82: 996-1000.
Bevan JS, Webster J, Burke CW, Scanion MF. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 1992; 13: 220-240.
Leong KS, Foy PM, Swift AC, Atkin SL, Hadden DR, MacFarlane IA. CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas. Clin Endocrinol 2000; 52: 43-49.